Home › Trial NCT03688204
Clinical Implementation of a Polygenic Risk Score (PRS) for Breast Cancer
- Trial IDNCT03688204
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorAmbry Genetics
- Enrollment118
- Start date2018-09-21
- ConditionsBreast Cancer Risk
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.